A pair of tests approved by the FDA in July give women the opportunity to collect their own samples in medical settings – similar to the way urine tests are handled.
EIGHT women who had their smear tests misread by screeners went on to develop cancer, a major review has found. Eleven more were found to have pre-cancerous changes to cells and needed treatment ...